Salta alla navigazione principale Salta alla ricerca Salta al contenuto principale

Prebiotics and probiotics as potential therapy for cognitive impairment

  • Alejandra Romo-Araiza
  • , Antonio Ibarra*
  • *Autore corrispondente per questo lavoro
  • Universidad Anáhuac

Risultato della ricerca

43 Citazioni (Scopus)

Abstract

Cognitive functions, such as learning and memory, may be impaired during aging. Age-related cognitive impairment is associated with selective neuronal loss, oxidative changes that lead to microglia activation and neuroinflammation. In addition, it is associated to alteration reduction in trophic factors affecting neurogenesis and synaptic plasticity. In recent years, attention has been paid to the relationship between gut microbiota and brain. In aging, there is an alteration in microbiota, gut microbiota diversity is perturbed with an increase in pathogenic bacteria at the expense of beneficial ones. Dysbiosis may lead to chronic inflammation, and a decrease in bacteria metabolites such as short-chain fatty acids which have been related to an upregulation of neurotrophic factors. Supplementation with prebiotics and probiotics can modulate gut microbiota, returning it to a more physiological state; thus, they may be considered as a possible treatment for age-related cognitive impairment.

Lingua originaleEnglish
Numero di articolo109410
RivistaMedical Hypotheses
Volume134
DOI
Stato di pubblicazionePublished - 1 gen 2020

Fingerprint

Entra nei temi di ricerca di 'Prebiotics and probiotics as potential therapy for cognitive impairment'. Insieme formano una fingerprint unica.

Cita questo